IQ-AI Limited IMAGING BIOMETRICS UPGRADES IB CLINIC(TM) SOFTWARE (5438G)

TIDMIQAI

RNS Number : 5438G

IQ-AI Limited

26 November 2020

26 November 2020

IQ-AI Ltd

("IQ-AI" or the "Company")

IMAGING BIOMETRICS UPGRADES IB CLINIC(TM) SOFTWARE

IQ-AI today announces that its subsidiary, Imaging Biometrics(R), LLC (IB), has made available release 20.11 of its IB Clinic(TM) software platform. The new release incorporates multiple new enhancement requests received from clients, as well as workflow efficiencies engineered by IB's developers. Ultimately, this release underscores IB's commitment to quality and helping clinicians improve care for their patients.

IB Clinic consists of perfusion weighted imaging and permeability computation modules IB Neuro and IB DCE, diffusion weighted imaging analysis module IB Diffusion, image co-registration and manipulation module IB Delta Suite, and IB Rad Tech, which streamlines and automates customizable workflows. While the products contained in IB Clinic continue to be available as plugins to the Mac-based medical imaging viewers, aycan workstation and OsiriX MD, they are also now available as platform-independent automated applications for both in-house and cloud-based processing. Both options generate consistent quantitative output regardless of where or when a patient is scanned, a feature unique to IB Clinic.

"This latest release further builds upon our proven track record of delivering scientifically proven advancements to clinicians," said Michael Schmainda, CEO of IB.

The Directors of the Company accept responsibility for the contents of this announcement.

-ENDS-

For further information, please contact:

 
 IQ-AI Limited 
  Trevor Brown/Vinod Kaushal/Qu Li 
  Tel: [phone] 
---------------------------------------------------------- 
 Peterhouse Capital Limited (Financial Adviser and Broker) 
  Lucy Williams/Heena Karani 
  Tel: [phone] 
---------------------------------------------------------- 
 

ABOUT Imaging Biometrics , LLC

Imaging Biometrics(R), a subsidiary of IQ-AI Limited (LON:IQAI), develops and provides visualisation and analytical solutions that enable clinicians to better diagnose and treat disease with greater confidence. Through close collaboration with top researchers and clinicians, sophisticated advancements are translated into platform-independent and automated software plug-ins which can extend the base functionality of workstations, imaging systems, PACS, or medical viewers. By design, IB's advanced visualisation software seamlessly integrates into routine workflows. For more information about Imaging Biometrics, visit the company's website at www.imagingbiometrics.com .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

PFUBABLTMTMTBIM

(END) Dow Jones Newswires

November 26, 2020 02:00 ET (07:00 GMT)